Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.956 EUR | -1.21% | -2.93% | -44.98% |
Apr. 04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
Apr. 03 | AB Science: reconsideration possible for masitinib in ALS | CF |
- Stock Market
- Equities
- AB Stock
- News AB Science